Price $8.64 |
Market Cap
1.69B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
8.0
|
P/B
1.75
|
P/S
1.67
|
Dividend %
-
|
|
P/CF
30.7
|
P/FCF
3.4
|
Op. Cash Flow
313.7K
|
FCF
2.0
|
|
Op. Margin
39.90%
|
Net Margin
13.90%
|
ROE
14.40%
|
ROI
47.80%
|
|
ROA
3.30%
|
EPS Growth
-76.40%
|
Current Ratio
7.7
|
Debt/Equity
95.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc (INM) | $0.27 | - | - | 1.6M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $15.72 | - | - | 1.19B | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
